Navigation Links
HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
Date:6/17/2013

gned to confirm observations from ENDURANCE that sites adhering to more regular monitoring and management of patient blood pressure witnessed a notably lower incidence of neurological events.  

In this supplemental cohort, HeartWare will enroll up to an additional 240 HeartWare HVAD patients, as well as up to an additional 120 control patients using a randomization scheme consistent with the ENDURANCE protocol.  Patients will be followed for 12 months after implant.  HeartWare intends to incorporate the data from this new cohort into an anticipated Pre-Market Approval (PMA) Application seeking approval of the HeartWare System for the Destination Therapy indication.  

Patient enrollment in this supplemental cohort can commence at the 50 centers participating in the ENDURANCE clinical trial, following edits to the protocol as prescribed by FDA and Institutional Review Board approvals at each of the centers.

On November 20, 2012, FDA granted approval of the HeartWare System for the Bridge-to-Transplant indication.  Concurrent with approval, the Company commenced a post-approval study (PAS) to assess device performance in a real-world setting.  HeartWare's PAS is a registry consisting of 600 patients who receive an HVAD and an additional 600 control patients derived from a contemporaneous group of continuous flow, intra-corporeal LVAD patients entered into the INTERMACS database.  HeartWare expects enrollment for both arms of the PAS will be complete by year's end. 

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally requir
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
2. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
3. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
4. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
5. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
6. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
7. HeartWare Schedules First Quarter Conference Call And Webcast
8. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
9. HeartWare International, Inc. Announces Public Offering of Common Stock
10. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
11. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... COVENTRY, R.I. , May 22, 2015 /PRNewswire/ ... a once-daily central nervous system stimulant indicated for ... available to patients beginning Summer 2015. ... Aptensio XR received approval from the U.S. Food ... XR is an extended-release formulation of methylphenidate capsule ...
(Date:5/21/2015)... , May 21, 2015 ... ) has announced the addition of the ... Type (Ankle Replacement, Digit Replacement, Elbow Replacement, ... Forecast to 2019" report to their ... for knee replacement was valued at $4,470.9 ...
(Date:5/21/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that its Board ... the second quarter 2015 of $0.03 per share of ... per share will be paid on June 19, 2015 ... 12, 2015.  The ex-dividend date for the quarterly dividend ...
Breaking Medicine Technology:Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... (NYSE Amex: CUR ) announced that it has ... Phase Ia trial to test the safety of NSI-189 for ... drug in healthy volunteers for safety and tolerability. NSI-189 is ... new neuron growth in the hippocampus, an area of the ...
... half of Americans take at least one prescription drug ... Prevention, yet many do not take advantage of the ... when it comes to their medications: their pharmacist. ... is reminding consumers about the importance of pharmacist consultations ...
Cached Medicine Technology:Neuralstem Updates NSI-189 Major Depression Trial 2Neuralstem Updates NSI-189 Major Depression Trial 3CVS/pharmacy Encourages Consumers to Consult With Pharmacists 2CVS/pharmacy Encourages Consumers to Consult With Pharmacists 3
(Date:5/23/2015)... 2015 Dr. David Benvenuti, an experienced plastic ... a new article to his website that takes ... Benvenuti explained in the fascinating blog, he has recently ... earlobes. , Known as “gauging,” the technique involves placing larger ... Benvenuti said will eventually stretch the holes out to incredible ...
(Date:5/23/2015)... Parker, CO (PRWEB) May 23, 2015 On ... participated in MuckFest. The event was a 5k mud obstacle ... affects more than 2 million people worldwide, and the reason ... our community,” said Chad Davis, owner of Farrell’s eXtreme Bodyshaping. ... National Multiple Sclerosis Society.” , The event was not only ...
(Date:5/23/2015)... 2015 Javon Bea Mercy Health ... Medicine and Rehabilitation Center, 557 N. Washington St., Janesville, ... 1-July 20, 5:30-6:30 pm. , The 8-week clinic is ... Finke, RN, BSN, who will offer training that encompasses ... running mechanics and show selection and weekly training plans. ...
(Date:5/22/2015)... The world is at a "hinge ... to create new opportunities for leadership in health ... WesternU's 34th annual Commencement Exercises said Wednesday, May ... former San Francisco mayor and likely 2018 gubernatorial ... ceremony for WesternU's colleges of Allied Health Professions ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Mountain Point Medical ... a ribbon cutting ceremony on Friday, May 29, 2015 at ... to 6 p.m. The new medical center, set to officially ... Triumph Boulevard, Lehi, UT 84043. , “The opening of ... team and the Utah County community,” said Kent Loosle, CEO ...
Breaking Medicine News(10 mins):Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Mountain Point Medical Center, a Campus of Jordan Valley Medical Center, Hosts Ribbon Cutting Ceremony and Community Celebration on Friday, May 29, 2015 2
... the researchers at the University of Southampton it was ... child's susceptibility to atherosclerosis. // ,The study analysed ... lower the mother's calorific intake during pregnancy, the thicker ... to measure the thickness of the wall of the ...
... an all time high in the United Kingdom, and space ... and pollution levels. //According to the Met office reports, during ... a record high in UK along with nitrogen dioxide pollution, ... ,These facts are dramatically demonstrated by the ...
... of malaria are reported each year. However, a revolutionary ... //with funding from the Bill & Melinda Gates Foundation, ... the disease. ,Design lecturer Dr Stephen Russell ... the Roslin Biocentre will develop a precisely engineered material ...
... disclosed the mechanism by which environmental stimulation decelerates ... physical activity //retards neurological decline. ,A paper ... al., "Reduction of amyloid angiopathy and A? ... involvement of multiple pathways," appears in the2006 August ...
... study published in the British Journal of Psychology showed that ... team of psychologist who wanted to test their theory linking ... hungry men preferred heavier women. ,Dr Viren ... Martin Tovee from Newcastle University conducted the study among 60 ...
... M.D., chief of transplantation at the Johns Hopkins University School ... kidney donors.// ,Domino transplants strategy if used ... scarcity in organ donation and reduce the waiting list. ... British journal Lancet. Domino transplants also serve the needs ...
Cached Medicine News:Health News:Sensor Images Show Soaring Temperature and Pollution Levels in UK 2Health News:Revolutionary Net To Control Malaria 2Health News:Active Life Decelerates Alzheimer's 2Health News:Domino Transplants Creates new wave In the Field Of Kidney Transplantation 2
... adjunctive treatment alternative in the treatment of ... the appendicular system. , Overview , ... leading provider of bone growth stimulators , ... or adjunct to surgery , Indicated for ...
... StoneLight Laser System is a solid state ... stones in all areas of the urinary ... spaces. , ,A variety of reusable fibers ... superior clinical versatility and outcomes. Standard 115V ...
... is proud to offer one ... the market at only 188 ... incorporates a superior flow rate ... locking mechanisms. The complementing electrodes ...
... PK Plasma-CISE™ (wire electrodes) and ... use devices that produce precise, ... thermal spread and Vapor sealing ... hemostasis. The devices provide excellent ...
Medicine Products: